Learn what the HHS 340B Drug Pricing Program is and what 340B hospitals are. The program allows 340B hospitals to stretch limited federal resources to reduce the price of outpatient pharmaceuticals ...

On October 26, 2023, the Health Resources and Services Administration (HRSA) issued a Notice to “inform and remind” 340B Program covered entities that to be considered eligible for the 340B program, ...

The 340B program spent $43.9 billion in 2021, supporting nearly 50,000 hospitals with discounted outpatient drugs. Cancer drugs constitute 41% of 340B purchases, with outpatient departments and ...

The results indicate that the program could play a role in discouraging use of biosimilars in the United States. Hospitals participating in the 340B Drug Pricing Program had lower biosimilar uptake, ...

Weaknesses in the oversight of the 340 drug-pricing program may allow some hospitals to get discounts they are ineligible for, a newly released report from the Government Accountability Office found.

___ Karen L. van Caulil, Ph.D., is the Executive Director of Floridians for Accountability in Health Care. Doug Wheeler is the Director of the George Gibbs Center for Economic Prosperity at The James ...

Under the 340B program, eligible hospitals buy drugs at a discounted price in order to offset the cost of treating low income ...

The name “340B” comes from the section of the U.S. Public Health Service Act of 1992 that requires pharmaceutical ...

The American Hospital Association, a Maine hospital group and four nonprofit systems are seeking a temporary restraining ...

The Patient Protection and Affordable Care Act is expected to bring significant change to the healthcare industry, including the expansion of the Public Health Service Act Section 340B Program.

Two recent federal court cases signal new significant developments with respect to the 340B Drug Pricing Program. Specifically: (1) new federal district court litigation challenging a recent HRSA ...